fluoxymesterone and Disease Exacerbation

fluoxymesterone has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersen, J; Andersson, M; Bastholt, L; Christensen, IJ; Dombernowsky, P; Kamby, C; Mouridsen, HT; Munkholm, P; Møller, KA; Rose, C1

Trials

1 trial(s) available for fluoxymesterone and Disease Exacerbation

ArticleYear
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age.
    Breast cancer research and treatment, 2000, Volume: 61, Issue:2

    Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Drug Synergism; Enzyme Inhibitors; Female; Fluoxymesterone; Humans; Hydrocortisone; Life Tables; Neoplasm Metastasis; Neoplasm Proteins; Salvage Therapy; Selective Estrogen Receptor Modulators; Survival Analysis; Tamoxifen; Treatment Outcome

2000